1-7 of 7
Igor Espinoza-Delgado
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer

Vered Stearns, Lisa K. Jacobs, MaryJo Fackler, Theodore N. Tsangaris, Michelle A. Rudek, Michaela Higgins, Julie Lange, Zandra Cheng, Shannon A. Slater, Stacie C. Jeter, Penny Powers, Susanne Briest, Calvin Chao, Carl Yoshizawa, Elizabeth Sugar, Igor Espinoza-Delgado, Saraswati Sukumar, Edward Gabrielson, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 4008–4016.
https://doi.org/10.1158/1078-0432.CCR-13-0033
Published: 15 July 2013
View article titled, Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
Open the PDF for Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

Ivana Gojo, Ming Tan, Hong-Bin Fang, Mariola Sadowska, Rena Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rakesh K. Srivastava, Igor Espinoza-Delgado, Douglas D. Ross
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1838–1851.
https://doi.org/10.1158/1078-0432.CCR-12-3165
Published: 02 April 2013
View article titled, Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia
Open the PDF for Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

Eudocia Q. Lee, Vinay K. Puduvalli, Joel M. Reid, John G. Kuhn, Kathleen R. Lamborn, Timothy F. Cloughesy, Susan M. Chang, Jan Drappatz, W. K. Alfred Yung, Mark R. Gilbert, H. Ian Robins, Frank S. Lieberman, Andrew B. Lassman, Renee M. McGovern, Jihong Xu, Serena Desideri, Xiabu Ye, Matthew M. Ames, Igor Espinoza-Delgado, Michael D. Prados, Patrick Y. Wen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 6032–6039.
https://doi.org/10.1158/1078-0432.CCR-12-1841
Published: 06 November 2012
View article titled, Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03
Open the PDF for Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03 in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Anastasios Stathis, Sebastien J. Hotte, Eric X. Chen, Holger W. Hirte, Amit M. Oza, Patricia Moretto, Sheila Webster, Anne Laughlin, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Wen-jiang Zhang, Igor Espinoza-Delgado, Julianne L. Holleran, Merrill J. Egorin, Lillian L. Siu
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1582–1590.
https://doi.org/10.1158/1078-0432.CCR-10-1893
Published: 15 March 2011
View article titled, Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Open the PDF for Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas in another window
Includes: Supplementary data
Journal Articles

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors

Marwan G. Fakih, Gerald Fetterly, Merrill J. Egorin, Josephia R. Muindi, Igor Espinoza-Delgado, James A. Zwiebel, Alan Litwin, Julianne L. Holleran, Kangsheng Wang, Robert B. Diasio
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14): 3786–3794.
https://doi.org/10.1158/1078-0432.CCR-10-0547
Published: 14 July 2010
View article titled, A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors
Open the PDF for A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors in another window
Journal Articles

Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

Ashraf Badros, Angelika M. Burger, Sunita Philip, Ruben Niesvizky, Sarah S. Kolla, Olga Goloubeva, Carolynn Harris, James Zwiebel, John J. Wright, Igor Espinoza-Delgado, Maria R. Baer, Julianne L. Holleran, Merrill J. Egorin, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5250–5257.
https://doi.org/10.1158/1078-0432.CCR-08-2850
Published: 12 August 2009
View article titled, Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Open the PDF for Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma in another window
Journal Articles

A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer

Marwan G. Fakih, Lakshmi Pendyala, Gerald Fetterly, Karoli Toth, James A. Zwiebel, Igor Espinoza-Delgado, Alan Litwin, Youcef M. Rustum, Mary Ellen Ross, Julianne L. Holleran, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3189–3195.
https://doi.org/10.1158/1078-0432.CCR-08-2999
Published: 30 April 2009
View article titled, A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
Open the PDF for A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer in another window